I agree that this site is using cookies. You can find further informations here.
X
Sahenk, Zarife
154  results:
Search for persons X
?
1

AAV1.NT-3 gene therapy prevents age-related sarcopenia:

Ozes, Burcak ; Tong, Lingying ; Myers, Morgan...
Aging.  , 2023
Link: https://doi.org/10.18632..
 
?
2

Long‐term safety and functional outcomes of delandistrogene..:

Mendell, Jerry R. ; Sahenk, Zarife ; Lehman, Kelly J....
Muscle & Nerve.  69 (2023)  1 - p. 93-98 , 2023
Link: https://doi.org/10.1002/..
 
?
3

A Phase 2 Clinical Trial Evaluating the Safety and Efficacy..:

Mendell, Jerry ; Shieh, Perry ; Sahenk, Zarife...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
4

P314: Long-term safety and sustained functional benefit in ..:

O'Rourke, Erin ; Mendell, Jerry R. ; Sahenk, Zarife...
Genetics in Medicine Open.  1 (2023)  1 - p. 100342 , 2023
Link: https://doi.org/10.1016/..
 
?
5

AAV1.NT‐3 gene therapy in the SOD1KO mouse model of acceler..:

Tong, Lingying ; Ozes, Burcak ; Moss, Kyle...
Journal of Cachexia, Sarcopenia and Muscle.  14 (2023)  5 - p. 2204-2215 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Expression of SRP-9001 dystrophin and stabilization of moto..:

Mendell, Jerry R. ; Shieh, Perry B. ; McDonald, Craig M....
Frontiers in Cell and Developmental Biology.  11 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
7

Long-term Safety and Efficacy in Patients with DMD 4 Years ..:

Mendell, Jerry ; Sahenk, Zarife ; Lehman, Kelly...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
8

Phase 1/2a Trial of SRP-9001 in Patients with Duchenne Musc..:

Mendell, Jerry R. ; Sahenk, Zarife ; Lehman, Kelly J....
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
9

eP201: A phase 2 clinical trial evaluating the safety and e..:

O'Rourke, Erin ; Mendell, Jerry ; Shieh, Perry...
Genetics in Medicine.  24 (2022)  3 - p. S124 , 2022
Link: https://doi.org/10.1016/..
 
?
10

A Phase 2 Clinical Trial Evaluating the Safety and Efficacy..:

Mendell, Jerry R. ; Shieh, Perry B. ; Sahenk, Zarife...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
11

Unmet Needs and Evolving Treatment for Limb Girdle Muscular..:

Pozsgai, Eric ; Griffin, Danielle ; Potter, Rachael...
Neurodegenerative Disease Management.  11 (2021)  5 - p. 411-429 , 2021
Link: https://doi.org/10.2217/..
 
?
12

AAV1.NT-3 gene therapy for X-linked Charcot–Marie–Tooth neu..:

Ozes, Burcak ; Myers, Morgan ; Moss, Kyle...
Gene Therapy.  29 (2021)  3-4 - p. 127-137 , 2021
Link: https://doi.org/10.1038/..
 
?
13

Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenot..:

Sahenk, Zarife ; Ozes, Burcak ; Murrey, Darren...
Molecular Therapy - Methods & Clinical Development.  22 (2021)  - p. 401-414 , 2021
Link: https://doi.org/10.1016/..
 
?
14

AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improve..:

Ozes, Burcak ; Moss, Kyle ; Myers, Morgan...
Brain Communications.  3 (2021)  4 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
15

Vasculitic neuropathy associated with IgG4-related kidney d..:

Jiang, Benjamin ; Sahenk, Zarife ; Satoskar, Anjali..
Clinical Nephrology.  96 (2021)  3 - p. 175-179 , 2021
Link: https://doi.org/10.5414/..
 
1-15